Compugen Narrows Q2 Net Loss, Appoints New CFO | GenomeWeb
NEW YORK (GenomeWeb News) - Compugen today posted $40,000 in revenues for the second quarter of 2008, compared to no revenues in the comparable period of 2007, accompanied by a 6 percent improvement in its second-quarter net loss.
The company also announced the appointment of Dikla Czaczkes Axselbard as chief financial officer, succeeding Ronit Lerner who resigned from the company. Axselbard served as director of finance for Compugen from 2002 through 2007, and has served as acting CFO since February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.